Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia

被引:39
作者
Shen, Yi [1 ]
Ding, Yuanjie [1 ]
Ma, Qing [2 ,3 ]
Zhao, Lei [4 ]
Guo, Xudong [1 ]
Shao, Yi [1 ]
Niu, Chen [1 ]
He, Yan [1 ]
Zhang, Feng [1 ]
Zheng, Deqiang [1 ]
Wei, Wenqiang [2 ,3 ]
Liu, Fen [1 ]
机构
[1] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing 100021, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
MICRORNA EXPRESSION PROFILE; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; CANCER; SERUM; SIGNATURES; PANEL; PROGRESSION; PROGNOSIS; MIR-92A;
D O I
10.1158/1055-9965.EPI-18-1199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating miRNAs have been identified as diagnostic biomarkers for esophageal squamous cell carcinoma (ESCC), but their efficacy in discovering early-stage ESCC is still unsatisfying. Esophageal squamous dysplasia (ESD) is the precursor lesion of ESCC. Notably, little is known about the role(s) of circulating miRNAs in identifying ESD. In this study, we, therefore, aimed to identify serum miRNAs as novel diagnostic markers for detecting ESD and ESCC. Methods: The genome-wide miRNA expression was profiled in 104 (52 ESCC and 52 controls) serum samples using microarray. Seven candidate miRNAs from the microarray assay were evaluated for their diagnostic performance in another cohort of 266 participants (96 ESCC, 92 ESD, and 78 healthy controls). Results: The serum levels of miR-16-5p, miR-197-5p, miR-451a, and miR-92a-3p were associated with ESCC; the biomarker based on the panel of these four miRNAs could efficiently distinguish patients with ESCC from the controls [AUC = 0.856; 95% confidence interval (CI), 0.794-0.905; P < 0.001]. The serum levels of miR-16-5p, miR-320c, miR-638, and miR-92a-3p were significantly higher in patients with ESD than in controls, and this four-miRNA signature could efficiently differentiate patients with ESD from the controls (AUC = 0.842; 95% CI, 0.778-0.893; P < 0.001). In addition, compared with serum carcinoembryonic antigen and carbohydrate antigen 199, miRNA-based panels had a better diagnostic performance in distinguishing patients with ESCC and ESD from healthy controls. Conclusions: Our study identified two novel panels of circulating miRNAs with high efficiency in detecting ESCC and ESD, suggesting that circulating miRNAs, in particular the combination of them, might serve as noninvasive biomarkers for the early detection of ESCC. Impact: This study suggests the feasibility of using circular miRNA-based blood tests to aid in the detection of ESD and ESCC.
引用
收藏
页码:1212 / 1220
页数:9
相关论文
共 47 条
[1]   Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Siegel, Rebecca L. ;
Torre, Lindsey A. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) :394-424
[2]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[3]   Identification of Circulating MicroRNA Signatures for Breast Cancer Detection [J].
Chan, Maurice ;
Liaw, Chiew Suan ;
Ji, Shen Mo ;
Tan, Hwee Huang ;
Wong, Chow Yin ;
Thike, Aye Aye ;
Tan, Puay Hoon ;
Ho, Gay Hui ;
Lee, Ann Siew-Gek .
CLINICAL CANCER RESEARCH, 2013, 19 (16) :4477-4487
[4]   microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin [J].
Chen, Zhao-li ;
Zhao, Xiao-hong ;
Wang, Ji-wen ;
Li, Bao-zhong ;
Wang, Zhen ;
Sun, Jian ;
Tan, Feng-wei ;
Ding, Da-peng ;
Xu, Xiao-hui ;
Zhou, Fang ;
Tan, Xiao-gang ;
Hang, Jie ;
Shi, Su-sheng ;
Feng, Xiao-li ;
He, Jie .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (12) :10725-10734
[5]   Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy [J].
Cheng, Guofeng .
ADVANCED DRUG DELIVERY REVIEWS, 2015, 81 :75-93
[6]   The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma [J].
Couch, George ;
Redman, James E. ;
Wernisch, Lorenz ;
Newton, Richard ;
Malhotra, Shalini ;
Dawsey, Sanford M. ;
Lao-Sirieix, Pierre ;
Fitzgerald, Rebecca C. .
CANCER PREVENTION RESEARCH, 2016, 9 (07) :558-566
[7]   miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients [J].
Dong, Lun ;
Li, Yuping ;
Han, Chongxu ;
Wang, Xiaodong ;
She, Lei ;
Zhang, Hengzhu .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) :746-756
[8]   Altered miRNA Expression is Associated with Differentiation, Invasion, and Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) in Patients from Huaian, China [J].
Fu, Hai Long ;
Wu, De Ping ;
Wang, Xiu Fang ;
Wang, Jian Guo ;
Jiao, Feng ;
Song, Lei Lei ;
Xie, Hui ;
Wen, Xu Yang ;
Shan, Hu Sheng ;
Du, Yun Xiang ;
Zhao, Ya Ping .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2013, 67 (02) :657-668
[9]   Distinctive MicroRNA profiles relating to patient survival in esophageal squamous cell carcinoma [J].
Guo, Yong ;
Chen, Zhaoli ;
Zhang, Liang ;
Zhou, Fang ;
Shi, Susheng ;
Feng, Xiaoli ;
Li, Baozhong ;
Meng, Xin ;
Ma, Xi ;
Luo, Mingyong ;
Shao, Kang ;
Li, Ning ;
Qiu, Bin ;
Mitchelson, Keith ;
Cheng, Jing ;
He, Jie .
CANCER RESEARCH, 2008, 68 (01) :26-33
[10]   Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients [J].
Hu, Jie ;
Wang, Zheng ;
Liao, Bo-Yi ;
Yu, Lei ;
Gao, Xue ;
Lu, Shaohua ;
Wang, Shuyang ;
Dai, Zhi ;
Zhang, Xin ;
Chen, Qing ;
Qiu, Shuang-Jian ;
Wu, Ying ;
Zhu, Hongguang ;
Fan, Jia ;
Zhou, Jian ;
Wang, Jiping .
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (05) :1187-1194